gabapentin
(Gabapentin)TAGI Pharma, Inc.
Usage: Gabapentin is indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures in adults and pediatric patients aged 3 years and older with epilepsy.
39 results
gabapentin
(Gabapentin)Actavis Pharma, Inc.Usage: Gabapentin capsules are indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures in adults and pediatric patients aged 3 years and older with epilepsy.gabapentin
(Gabapentin)BioComp Pharma, Inc.Usage: Gabapentin oral solution is indicated for managing postherpetic neuralgia in adults and as adjunctive therapy for partial onset seizures in adults and pediatric patients aged 3 and older with epilepsy.keppra
(levetiracetam)UCB, Inc.Usage: KEPPRA is indicated for treating partial-onset seizures in patients aged 1 month and older. It is also approved as adjunctive therapy for myoclonic seizures in patients 12 years and older with juvenile myoclonic epilepsy and for primary generalized tonic-clonic seizures in patients 6 years and older with idiopathic generalized epilepsy.lacosamide
(lacosamide)Glenmark Pharmaceuticals Inc. USAUsage: Lacosamide tablets are indicated for treating partial-onset seizures in patients aged 4 years and older. Additional pediatric usage information exists but is not included on the label due to marketing exclusivity rights.lacosamide
(Lacosamide)Zydus Pharmaceuticals USA Inc.Usage: Lacosamide is indicated for the treatment of partial-onset seizures and as adjunctive therapy for primary generalized tonic-clonic seizures in patients aged 4 years and older.lacosamide
(lacosamide)Sintetica US LLCUsage: Lacosamide Injection is indicated for the treatment of partial-onset seizures and as adjunctive therapy for primary generalized tonic-clonic seizures in patients aged 4 years and older.lacosamide
(Lacosamide)Zydus Pharmaceuticals USA Inc.Usage: Lacosamide is indicated for treating partial-onset seizures in patients aged 4 and older and as adjunctive therapy for primary generalized tonic-clonic seizures in the same age group.lamotrigine
(lamotrigine extended-release)Yiling Pharmaceutical, Inc.Usage: Lamotrigine Extended-Release Tablets are indicated for adjunctive therapy in patients aged 13 and older with primary generalized tonic-clonic seizures and partial-onset seizures. They can also be used for conversion to monotherapy in individuals with partial-onset seizures on a single antiepileptic drug. Safety is not established in patients under 13.lamotrigine
(Lamotrigine)Taro Pharmaceuticals U.S.A., Inc.Usage: Lamotrigine is indicated as adjunctive therapy for partial-onset, primary generalized tonic-clonic, and Lennox-Gastaut syndrome seizures in patients aged 2 and older, and for conversion to monotherapy in adults with partial-onset seizures. It is also used for the maintenance treatment of bipolar I disorder to delay mood episodes.